-
Morning Buzz: Affimed N.V. (NASDAQ:AFMD), Merrimack Pharmaceuticals (NASDAQ:MACK), Eagle Bancorp (NASDAQ:EGBN), Diana Shipping Inc. (NYSE:DSX), Unwired Planet (NASDAQ:UPIP)
On Friday shares of Affimed N.V. (NASDAQ:AFMD) closed at $8.35. Affimed NV (NASDAQ:AFMD)‘s stock had its “buy” rating reiterated by equities research analysts at Jefferies Group in a research note issued to investors on Saturday. They currently have a $12.00 price objective on the stock. Jefferies Group’s price objective would suggest a potential upside of…
-
Active Watch List: Merrimack Pharmaceuticals (NASDAQ:MACK), Alcatel Lucent SA (ADR) (NYSE:ALU), Popular (NASDAQ:BPOP), Esterline Technologies Corp. (NYSE:ESL), Pfizer Inc. (NYSE:PFE)
On Monday shares of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) closed at $12.88. Company’s sales growth for last 5 years was 117.70% and EPS growth for next 5 years is recorded as 5.60%. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that it will present preclinical and clinical data showcasing its deep oncology pipeline at the 2015 American Association for…
-
Hot News: Ford Motor Company (NYSE:F), Merrimack Pharmaceuticals (NASDAQ:MACK), Alcatel Lucent SA (ADR) (NYSE:ALU), CIFC Corp. (NASDAQ:CIFC), First Midwest Bancorp (NASDAQ:FMBI)
On last trading day Ford Motor Company (NYSE:F) decreased -1.00% to close at $15.87. Its volatility for the week is 1.05% while volatility for the month is 1.40%. F’s sales growth for past 5 years was 4.40% and its EPS growth for past 5 years was -1.40%. Ford Motor Company (NYSE:F) monthly performance is -1.86%.…
-
Morning Alert: Merrimack Pharmaceuticals (NASDAQ:MACK), Visa Inc. (NYSE:V), Dipexium Pharmaceuticals (NASDAQ:DPRX), ImmunoCellular Therapeutics, (NYSEMKT:IMUC)
On Monday shares of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) closed at $11.87. Company’s sales growth for last 5 years was 117.70% and EPS growth for next 5 years is recorded as 5.60%. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that it will present preclinical and clinical data showcasing its deep oncology pipeline at the 2015 American Association for…
-
Trending Stocks: Merrimack Pharmaceuticals (NASDAQ:MACK), Papa Murphy’s Holdings (NASDAQ:FRSH), Advaxis (NASDAQ:ADXS), Zynga Inc (NASDAQ:ZNGA), Magnum Hunter Resources Corp. (NYSE:MHR)
On Thursday shares of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) closed at $12.08. Company’s sales growth for last 5 years was 117.70% and EPS growth for next 5 years is recorded as 5.60%. On March 12, Advanced Cell Diagnostics, Inc. (ACD) announced that Merrimack Pharmaceutical Inc. (NASDAQ:MACK) is utilizing their leading technology to choose participants for a…
-
Momentum Stocks: Apricus Biosciences (NASDAQ:APRI), Merrimack Pharmaceuticals (NASDAQ:MACK), Amkor Technology (NASDAQ:AMKR), JA Solar Holdings Co., (NASDAQ:JASO), Chevron (NYSE:CVX)
On Monday shares of Apricus Biosciences, Inc. (NASDAQ:APRI) closed at $1.94. Company’s sales growth for last 5 years was -16.10%. Apricus Biosciences, Inc. (NASDAQ:APRI) reported a Q4 net loss of $17.3 million, or $0.40 per share, compared with a net loss of $1.3 million, or $0.04 per share for Q4 2013. The company noted the…
-
Stocks News Alert: Kinross Gold (NYSE:KGC), Merrimack (NASDAQ:MACK), Silver Standard Resources (NASDAQ:SSRI), Great Lakes Dredge & Dock (NASDAQ:GLDD), Sabine Royalty Trust (NYSE:SBR)
Shares of Kinross Gold (NYSE:KGC) have received an average rating of “Hold” from the seventeen analysts that are covering the company, American Banking News reports. Two analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and three have issued a buy recommendation on the company. On Thursday shares of…
-
Top Movers: Teva Pharmaceutical Industries Limited (NYSE:TEVA), United States Steel Corp. (NYSE:X), Merrimack Pharmaceuticals (NASDAQ:MACK), GNC Holdings (NYSE:GNC), RadiSys (NASDAQ:RSYS)
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the Barclays Global Healthcare Conference in Miami, FL. Eyal Desheh, Group EVP & CFO will present on Thursday, March 12, 2015 at 8:30 AM ET. On Wednesday shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) closed at $57.61. Company’s sales growth for last 5…
-
Investors Are Eying: Geron Corporation (NASDAQ:GERN), Merrimack Pharmaceuticals (NASDAQ:MACK), Nationstar Mortgage Holdings Inc. (NYSE:NSM), Express Scripts Holding (NASDAQ:ESRX), Canadian Solar (NASDAQ:CSIQ)
On 3 March 2015, Geron Corporation (NASDAQ:GERN) 4Q2014 net loss came at $8.9 million compared to $9.3 million for the comparable 2013 period. The revenue in 4Q2014 came at $178,000 compared to $225,000 in 4Q2013. The cash and investments at the end of FY2014 came at $170.6 million. On Wednesday shares of Geron Corporation (NASDAQ:GERN)…
-
Market Watch: Merrimack Pharmaceuticals (NASDAQ:MACK), Facebook Inc (NASDAQ:FB), Trex Co. Inc. (NYSE:TREX), Johnson & Johnson (NYSE:JNJ), Entravision Communications Corporation (NYSE:EVC)
Advanced Cell Diagnostics announced that Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) will use its RNAscope technology for Merrimack’s Phase II clinical trial of its drug candidate for metastatic non-small cell lung cancer. On Monday shares of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) closed at $12.03. Company’s sales growth for last 5 years was 117.70% and EPS growth for next…